Risa Ide
Overview
Explore the profile of Risa Ide including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takahashi H, Ide R, Narusawa Y, Maejima T, Matsumura H
Cureus
. 2024 Aug;
16(7):e63808.
PMID: 39105024
Superficially spreading cervical squamous cell carcinoma (SCC) is the superficial extension of SCC of the cervix into the uterine lumen, replacing the endometrium. Here, we report a case of superficially...
2.
Ide R, Ogata M, Iwasaki N, Babazono T
Diabetol Int
. 2019 Oct;
10(4):268-278.
PMID: 31592403
Objective: Resting energy expenditure (REE) is an important tool in nutrition management, especially in type 2 diabetes mellitus (T2DM). The predicted REE (pREE) was reported to be inaccurate, compared with...
3.
Ogata M, Iwasaki N, Ide R, Takizawa M, Tanaka M, Tetsuo T, et al.
J Diabetes Investig
. 2017 Apr;
9(1):211-222.
PMID: 28371517
Aims/introduction: Resting energy expenditure was associated with a serum bone turnover marker in postmenopausal women with type 2 diabetes (T2DMPW) in the present cross-sectional study. To clarify the fundamental pathological...
4.
Iwasaki N, Tsurumi M, Asai K, Shimuzu W, Watanabe A, Ogata M, et al.
Hum Genome Var
. 2016 Jul;
3:16022.
PMID: 27468355
The hepatocyte nuclear factor 1β gene (HNF1B) is responsible for maturity-onset diabetes of the young type 5 (MODY5), which is characterized by early-onset diabetes mellitus and urogenital malformations. HNF1B is...
5.
Ogata M, Ide R, Takizawa M, Tanaka M, Tetsuo T, Sato A, et al.
Nutrition
. 2015 Oct;
31(11-12):1394-401.
PMID: 26429661
Objective: Diabetes is a risk factor for osteoporosis, and glycemic control is critical during osteoporosis treatment in patients with type 2 diabetes (T2D). However, diabetic therapies have potentially adverse effects...
6.
Ogata M, Iwasaki N, Ide R, Takizawa M, Uchigata Y
Biochem Biophys Res Commun
. 2014 Apr;
447(1):133-8.
PMID: 24709081
Glucagon-like peptide (GLP)-1 analog based therapies are used not only for their insulinotropic effects, but also for their pleiotropic effects that improve pancreatic β cell function. Liraglutide is a long...